DATED 13 December 2010 IMMUTEP S.A. - and - GLAXO GROUP LIMITED LICENCE & RESEARCH COLLABORATION AGREEMENTCollaboration Agreement • September 23rd, 2019 • IMMUTEP LTD • Pharmaceutical preparations • England
Immutep is a biotechnology company, which has developed expertise in relation to the Monoclonal Antibody with LAG-3 positive (LAG-3+) cell depleting activity (as defined below).
